A Phase II Study to Investigate the Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

Trial Profile

A Phase II Study to Investigate the Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Mar 2012

At a glance

  • Drugs Dexloxiglumide (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2012 Actual patient number is 48 as reported by ClinicalTrials.gov.
    • 02 Mar 2012 Actual end date (1 Aug 2007) added as reported by ClinicalTrials.gov.
    • 21 Apr 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top